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ratories. Molecular assays have high sensitivity and specicity for 
the detection of inuenza virus; however, usually, appropriate 
laboratory settings and well-trained technicians are required to 
perform these tests. In contrast, rapid inuenza diagnostic tests 
(RIDTs) are easier to handle and can detect inuenza viral anti-
gens in 10-15 minutes, making them valuable in the outpatient 
setting. Accordingly, RIDTs are widely used for the diagnosis of 
inuenza as an initial step in clinical elds [2, 4]. Since results 
from RIDT methods are available before those from PCR or im-
munoassays, clinicians can make decisions on whether to start 
antiviral treatment based on these results [4]. However, the sensi-
tivity of RIDTs is highly variable—ranging from 40-98% [2, 5, 6]—
which can frequently lead to false negative results, thereby mak-
ing it important to recognize the limitation of these methods while 
interpreting the results. In this study, we evaluated the diagnostic 
performance of a new RIDT, SD Standard F inuenza A/B FIA 
(Standard F; SD Biosensor, Inc., Suwon, Korea), by comparing its 
performance with that of the commercially available RIDT, BD 
Veritor Flu A+B (Veritor; Becton Dickinson and Company Diag-
nostic, Sparks, MD, USA), relative to RT-PCR.
Inuenza causes a broad range of illnesses, and its diagnosis 
based solely on clinical symptoms is difcult [1]. There are several 
diagnostic methods currently available including viral culture, 
molecular assays, serologic tests, and antigen detection tests. The 
sensitivity and specicity of the assays used for the detection of 
inuenza virus vary depending on the type of method used [2, 3]. 
Molecular methods including rapid molecular assay and reverse 
transcription polymerase chain reaction (RT-PCR) are widely used 
as the standard methods for diagnosing inuenza in clinical labo-
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Rapid influenza diagnostic test (RIDT) is widely used for the diagnosis of influenza owing to its simplicity and convenience of use. This study aimed 
to evaluate the performance of a new RIDT, SD Standard F influenza A/B FIA (SD Biosensor, Inc., Korea) (Standard F) and compare its perfor-
mance with BD Veritor Flu A+B (Veritor), using the results of real-time reverse transcription PCR (rRT-PCR) analysis as the standard for refer-
ence. On comparing the results obtained from both the RIDTs and rRT-PCR qualitatively, it was found that the Veritor and Standard F assays have 
the sensitivity of 65.6% (21/32) and 71.9% (23/32), respectively, for the detection of influenza A with a specificity of 100.0% (68/68). Additional-
ly, both the assays demonstrated a sensitivity of 66.7% (12/18) and specificity of 100.0% (68/68) for the detection of influenza B. The cutoff index 
(COI) value of the fluorescence color intensity from the Standard F assay, displayed on the device along with the qualitative results, indicated a 
negative correlation with the Ct value from rRT-PCR for both influenza A and B (P <0.001). The sensitivity of the new RIDT for the detection of influ-
enza was comparable with that of the Veritor assay and the new RIDT could be used as a substitute for existing RIDTs by providing additional in-
formation to predict the approximate viral burden of influenza.
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Both RIDTs involve immunochromatographic detection of nu-
cleoprotein antigens of inuenza A or B. The inuenza viral anti-
gens bind to the anti-inuenza antibodies conjugated to detector 
particles in the test strip [7]. The difference between the two RIDTs 
is that the Veritor uses colloidal-gold detector particles, whereas 
the Standard F uses uorescent dyes as the detector. The results 
of both the assays are interpreted by a digital reading instrument. 
In case of the Veritor, only qualitative results such as positive or 
negative are displayed, whereas in Standard F, the qualitative re-
sults along with the uorescence intensities as cutoff index (COI) 
values are displayed. According to the Standard F manufacturer’s 
instructions, test results of COI ≥1.00 are presented as positive 
and below 1.00 as negative for inuenza. 
We used 117 left-over, non-duplicated, nasopharyngeal samples 
from patients who visited the Severance hospital with a u-like ill-
ness (fever >37.8°C and/or clinical symptoms of headache, cough, 
sore throat, and myalgia) from January 2018 to April 2018; the sam-
ples were from 12 adults and 105 children ranging from less than 
one to 17 years of age (median age, 2 years old). All the samples 
were analyzed by the AdvanSure RV real-time RT-PCR assay (rRT-
PCR; LG Life Sciences, Seoul, Korea) and immediately preserved 
at -70°C after rRT-PCR. The thawing process was perfomed at 
room temperature (15-30°C) before analyzing the samples using 
the two RIDTs. The two RIDTs were performed simultaneously 
and all the results obtained were compared with those from the 
rRT-PCR analysis. We interpreted samples with a cycle threshold 
(Ct) value <25.00 as a positive result according to the manufac-
turer’s instructions. This study has been approved by the Institu-
tional Review Board (IRB) of Yonsei University College of Medi-
cine (IRB 1-2017-0093). 
Sensitivity, specicity, positive predictive value, and negative 
predictive values with 95% condence intervals (CIs) were calcu-
lated using standard formulas. Statistical analysis was performed 
using Microsoft Excel (Microsoft Corporation, WA, USA) and Anal-
yse-it software, Method Evaluation edition version 5.11 (Analyze-it 
Software LTD, City West Business Park, Leeds, UK). Pearson cor-
relation coefcient was calculated to evaluate the correlation be-
tween the Ct values from rRT-PCR and COI values from the Stan-
dard F. P values <0.05 were considered to indicate statistical sig-
nicance.
Sensitivity and specicity of the two RIDTs for the detection of 
inuenza are shown in Table 1. After rRT-PCR analysis for inu-
enza A and B (A/B), 31 of the 117 specimens were found to be A 
positive/B negative, 17 were A negative/B positive, only one was 
A positive/B positive, and the rest 68 were A negative/B negative. 
Using rRT-PCR as the testing standard, the Veritor and Standard F 
assays were found to demonstrate a sensitivity of 65.6% (21/32) 
and 71.9% (23/32), respectively, for the detection of inuenza A 
with a detection specicity of 100.0% (68/68). Additionally, both 
the assays demonstrated a sensitivity of 66.7% (12/18) and speci-
city of 100.0% (68/68) for the detection of inuenza B. Fig. 1 shows 
comparison of Ct values of the inuenza-positive specimens. A 
total of 49 samples were found to be positive by rRT-PCR, and al-
most all the samples with low Ct values, below 14.4 for inuenza 
A and 13.3 for inuenza B, were detected by both the assays.
In our study, Standard F showed a diagnostic performance com-
parable with that of Veritor in detecting inuenza A infection with 
a higher sensitivity. Two out of the 31 rRT-PCR inuenza A posi-
tive samples (Ct value of 9.79 and 20.31) showed discordant results 
between the two RIDTs, positive by Standard F and negative by 
Table 1. Performance of two rapid influenza diagnostic tests for the detection of influenza in comparison with rRT-PCR
Rapid test 
rRT-PCR test % (95% CI)
A B A+B N Sensitivity Specificity
Veritor A 20 0 0 0 65.6 (46.8-81.4) 100.0 (94.7-100.0)
B 0 11 0 0 66.7 (40.1-86.1) 100.0 (94.7-100.0)
A+B 0 0 1 0
N 11 6 0 68
Standard F A 22 0 0 0 71.9 (53.3-86.3) 100.0 (94.7-100.0)
B 0 11 0 0 66.7 (40.1-86.1) 100.0 (94.7-100.0)
A+B 0 0 1 0
N 9 6 0 68
Abbreviations: rRT-PCR, real-time reverse transcription polymerase chain reaction; A, influenza A; B, influenza B; A+B, influenza A, B co-infection; N, negative; Veritor, BD 
Veritor assay; Standard F, SD Standard F assay.
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Veritor. Those cases were clinically diagnosed with inuenza A 
infection and treated with medication, which was in line with the 
results obtained by the Standard F method. Our result is compara-
ble with a previous report that reveals improved sensitivity and a 
lowered limit of detection (LOD) of uorescent immunochromato-
graphy-based assays compared to that of colloidal gold-based rapid 
diagnostic kits [8]. However, the sensitivity of both the RIDT as-
says was lower than the value suggested by the manufacturer. The 
Fig. 1. Comparison of cycle threshold (Ct) values of the influenza-positive specimens. (A), influenza A: N=32 and (B), influenza B: N=18. Specimens 
with negative RIDT results are indicated by an empty box. The maximum Ct value with positive RIDT result was 20.31 and 13.26 for influenza A and 
B, respectively. 
Abbreviations: rRT-PCR, real-time reverse transcription polymerase chain reaction; RIDT, rapid influenza diagnostic test; Veritor, BD Veritor assay; 






























Fig. 2. Correlation of cutoff index (COI) values obtained from SD Standard F assay with cycle threshold (Ct) values of influenza-positive specimens. 
(A), influenza A and (B), influenza B.
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differences in sensitivity could be due to the nature of the sam-
ples that we used. The study was conducted using samples that 
were preserved at -70°C after RT-PCR analysis. It is possible that 
degradation of the antigens during the thawing process could 
have resulted in the unexpectedly lower sensitivity values [9]. It is 
possible that the RIDT assays could not detect certain inuenza-
positive samples conrmed by PCR due to the presence of an al-
tered epitope due to minor changes in the protein structure that 
was not detectable by the kit, and this could have led to differences 
between the sensitivity reported in our study and that suggested 
by the manufacturer [10].
The Standard F test displayed not only qualitative results but 
also quantitative COI values. The COI values displayed a moder-
ate negative correlation with Ct values of the inuenza-positive 
specimens (inuenza A: R= -0.77, P<0.001; inuenza B: R= -0.88, 
P<0.001; Fig. 2). Kim et al. [11] and Ryu et al. [12] studied dilution 
tests for uorescent lateral ow immunoassays and described a 
correlation between the COI values and concentration of the tar-
get epitope such as rotavirus and antibody to hepatitis B surface 
antigen. Our results also demonstrate that the COI values might 
reect the inuenza viral load and can help estimate the relative 
amount of inuenza antigen. Therefore, the COI values can pro-
vide additional information and guidance to a clinician analyzing 
the negative results. If the result of a symptomatic patient is nega-
tive with a COI value just below the cut-off level, a clinician can 
consider the possibility of early infection with low viral load; in 
such circumstances, a repeat test can be conducted within a short 
time-frame, or other viral assays such as RT-PCR can be given im-
mediate consideration. 
Consistent with previous studies, the two RIDTs showed a slightly 
higher overall sensitivity for inuenza A (65.6%-71.9 %) than for in-
uenza B (66.7%) [5, 13-15] and the sensitivity and specicity of 
both the RIDTs were higher than the pooled values of sensitivity 
and specicity of 53.2%-62.3% and 98.2%-99.8%, respectively [2, 
5]. An earlier study of the Veritor test revealed a sensitivity of 73.0%-
93.8% for inuenza A and 55.6%-94.2% for inuenza B, and an 
overall specicity greater than 95% [2, 7, 14, 16-19]. These values 
are slightly higher than those reported in our current study. These 
wide ranges of sensitivity can be explained by factors including 
specimen type, assay kit lot, the phase of infection (related to vi-
ral load and shedding), and differences in the targeted study pop-
ulation; the sensitivity of the tests has been found to be higher for 
samples obtained from children [9, 18, 20].
Our study has some limitations. First, we conducted this study 
with a small number of samples. In addition, we did not use fresh 
samples, and this might have had a negative inuence on the sen-
sitivity of the assays.
In conclusion, the Standard F method shows a comparable re-
sult for diagnosing inuenza infection, is as sensitive as other RIDTs, 
and provides additional semi-quantitative information that can aid 
in diagnosis. 
요  약
인플루엔자 신속진단검사(rapid inuenza diagnostic test, RIDT)
는 사용의 편리함과 간편함으로 현재 인플루엔자 진단에 널리 사
용되고 있다. 이 연구에서는 실시간 역전사 PCR (rRT-PCR)의 결과
를 기준으로 새로운 국산 신속검사 키트인 SD Standard F inu-
enza A/B FIA (SD Biosensor, Inc., Korea) (Standard F)와 BD Veri-
tor Flu A+B (Veritor)의 성능을 비교 평가하였다. 본 연구에서 인플
루엔자 A 검출에 대해 Veritor 및 Standard F 검사는 각각 65.6% 및 
71.9%의 민감도와 100.0%의 특이도를 보였다. 인플루엔자 B 검출
에 대해서는 두 RIDT 모두 66.7%의 민감도와 100.0%의 특이도를 
보였다. Standard F assay에서 추가적으로 제시하는 형광 강도의 
판정 기준치(cutoff index, COI)는 인플루엔자 A와 B에서 모두 
rRT-PCR의 Ct 값과 음의 상관 관계를 보였다(P<0.001). Standard F
는 기존의 신속검사 키트인 Veritor와 비교하여 유사한 민감도를 
보였으며 추가적으로 인플루엔자 바이러스의 부하를 예측하는데 
도움을 줄 수 있어 인플루엔자 바이러스 감염의 신속진단검사로 
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